198 related articles for article (PubMed ID: 24733351)
1. The regulatory sciences for stem cell-based medicinal products.
Yuan BZ; Wang J
Front Med; 2014 Jun; 8(2):190-200. PubMed ID: 24733351
[TBL] [Abstract][Full Text] [Related]
2. Establishing a Quality Control System for Stem Cell-Based Medicinal Products in China.
Yuan BZ
Tissue Eng Part A; 2015 Dec; 21(23-24):2783-90. PubMed ID: 25471126
[TBL] [Abstract][Full Text] [Related]
3. Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects.
Liras A
J Transl Med; 2010 Dec; 8():131. PubMed ID: 21143967
[TBL] [Abstract][Full Text] [Related]
4. Future development of global regulations of Chinese herbal products.
Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Stem Cell-Based Research in India in Comparison with the US, EU and other Asian Countries: Current Issues and Future Perspectives.
Jose J; George T; Thomas AM
Curr Stem Cell Res Ther; 2020; 15(6):492-508. PubMed ID: 32250233
[TBL] [Abstract][Full Text] [Related]
6. Regulation of stem cell-based therapies in Canada: current issues and concerns.
von Tigerstrom B; Nguyen TM; Knoppers BM
Stem Cell Rev Rep; 2012 Sep; 8(3):623-8. PubMed ID: 22410974
[TBL] [Abstract][Full Text] [Related]
7. 2005 Donor Eligibility Requirements: Unintended Consequences for Stem Cell Development.
Couture LA; Carpenter MK
Stem Cells Transl Med; 2015 Oct; 4(10):1097-100. PubMed ID: 26285658
[TBL] [Abstract][Full Text] [Related]
8. Fraudsters operate and officialdom turns a blind eye: a proposal for controlling stem cell therapy in China.
Jiang L; Dong BH
Med Health Care Philos; 2016 Sep; 19(3):403-10. PubMed ID: 26906907
[TBL] [Abstract][Full Text] [Related]
9. The challenges of regulating stem cell-based products.
von Tigerstrom BJ
Trends Biotechnol; 2008 Dec; 26(12):653-8. PubMed ID: 18977047
[TBL] [Abstract][Full Text] [Related]
10. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
[TBL] [Abstract][Full Text] [Related]
12. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
Kroes BH
J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
[TBL] [Abstract][Full Text] [Related]
13. Regulations and guidelines governing stem cell based products: Clinical considerations.
George B
Perspect Clin Res; 2011 Jul; 2(3):94-9. PubMed ID: 21897884
[TBL] [Abstract][Full Text] [Related]
14. [Safety monitoring of cell-based medicinal products (CBMPs)].
Funk MB; Frech M; Spranger R; Keller-Stanislawski B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1239-46. PubMed ID: 26391098
[TBL] [Abstract][Full Text] [Related]
15. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
16. Structure, control and regulation of the formal market for medicinal plants' products in Nigeria.
Oguntade AE; Oluwalana IB
Afr J Tradit Complement Altern Med; 2011; 8(4):370-6. PubMed ID: 22654213
[TBL] [Abstract][Full Text] [Related]
17. [European Marketing Authorisation: a long process. Experiences of small biotech companies with the ATMP regulation].
Buljovčić Z
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):831-8. PubMed ID: 21698536
[TBL] [Abstract][Full Text] [Related]
18. [The regulatory framework for complementary and alternative medicines in Europe].
Knöss W; Stolte F; Reh K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):771-8. PubMed ID: 18584103
[TBL] [Abstract][Full Text] [Related]
19. Medicinal Product Regulation: Portugal׳s Framework.
Herdeiro MT; Bastos PD; Teixeira-Rodrigues A; Roque F
Clin Ther; 2016 Sep; 38(9):2118-2126.e2. PubMed ID: 27574988
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
